Inside out: looking within our bodies improves drug design

Researchers from the IMIM Systems Pharmacology Research Group have analyzed 566 drugs and their endogenous ligands. The results help predict whether a drug may have undesired side effects.

The Systems Pharmacology group of GRIB has established for the first time a quantitative relationship between the affinities of the endogenous metabolites and of the drugs for the same proteins. Read the full interview to Jordi Mestres, head of this group, at the last edition of el·lipse magazine.

Site Information